Tech /

Policy

Related Topics:
Made in China 2025

China’s new drug insurance: lifeline for patients or squeeze on big firms?

New insurance formulary trims costs of Alzheimer’s and cancer therapies and marks a small win for global novel drug makers.

Xpeng, Li Auto given approval to test ‘hands-off’ L3 cars amid slowing market

Why Nvidia chip is unlikely to derail ambitions of China’s Huawei, Moore Threads

China’s huge demand for AI computing power leaves room for growth for both US and domestic chips, analysts say.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW